Dr. Mohammed S. Abdulghani, MD

Dr. Abdulghani practices at VCU Medical Center in Richmond, Virginia, part of Commonwealth of Virginia.

Dr. Abdulghani's NPI, 1760864003, was assigned on June 23, 2015. Dr. Abdulghani holds Virginia license 0101264263.

Dr. Abdulghani's primary practice is VCU Medical Center, at 1250 East Marshall Street, Richmond, VA 23298 in Richmond City. The practice phone is (804) 828-9000.

Dr. Abdulghani's primary practice is VCU Medical Center in Richmond, Virginia, part of Commonwealth of Virginia. Dr. Abdulghani is also affiliated with VCU Health Tappahannock Hospital. The medical group on file is MCV Physicians. Dmand AI also links Dr. Abdulghani to 1 more urgent care center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abdulghani practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Abdulghani's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Abdulghani is licensed in Virginia.

CMS data shows 355 Medicare services from Dr. Abdulghani across 6 procedure codes in 2024, for 137 Medicare patients. Medicare paid $24,863 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 137 Medicare patients who saw Dr. Abdulghani in 2024. The largest group is 75 to 84, with 45 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 3.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abdulghani's median patient age at 68, with 57% women.

In 2024, Dr. Abdulghani wrote 28 Medicare Part D claims for 16 patients. 86% of them were for generic drugs. CMS names the drug for 24 of them, across 2 drugs with 11 or more claims each, at $2,525 in total drug cost. In 2017, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Abdulghani for performance year 2024, reported as part of a group. Dr. Abdulghani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Abdulghani, published from 2014 to 2020. 2015 was the busiest year, with 2. The most frequent topics are Tachycardia, Ventricular, 3-Iodobenzylguanidine and Algorithms. Dr. Abdulghani's most frequent co-authors are Stephen Ross Shorofsky, MD, Wengen Chen, MD and Vasken Dilsizian, MD.

CMS Open Payments shows 1 general payment to Dr. Abdulghani from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $103.